NONMEM® is the most-widely used nonlinear mixed effects modelling tool introduced into population PK/PD analysis. Even though thousands of pharmaceutical scientists utilize NONMEM® routinely for their data analysis, the various estimation methods implemented in NONMEM® remain a mystery for most users due to the complex statistical and mathematical derivations underlying the algorithm used in NONMEM®. In this tutorial, we demonstrated how to directly obtain the objective function value and post hoc η for the first order approximation method by the use of R. We hope that this tutorial helps pharmacometricians understand the underlying estimation process of nonlinear mixed effects modelling.
Introduction
The nonlinear mixed effects method that was introduced to the biomedical research field approximately 30 years ago is now an essential platform in population pharmacokinetic and pharmacodynamic (PK/PD) data analysis. [1] [2] [3] NONMEM® is the most-widely used nonlinear mixed effects modelling tool introduced for population PK/PD analysis since its prototype was developed by Lewis B. Sheiner and Stuart L. Beal of the University of California, San Francisco. [4] It is programmed in FORTRAN code and has evolved to its current version, 7.3. NONMEM® is regarded as the standard pharmacometrics tool. Even though thousands of pharmaceutical scientists utilize NONMEM® routinely for their data analysis, the various estimation methods implemented in NONMEM® remain a mystery for most users due to the complex statistical and mathematical derivations underlying the algorithm used in NONMEM®. Wang systematically derived the objective functions for the major estimation methods used in NONMEM® and clearly demonstrated their relationships through the derivation. [5] Wang derived the first-order (FO) method from an approximation of the Laplacian method, whereas we derived the FO method directly from the maximum likelihood estimation method. R is a computer language and suite of libraries for statistical and mathematical computation. It has a strong but relatively small base system compared with other commercial software like SAS® and SPSS®. However, R has robust functions for scientific computation and many add-in packages for particular problems and situations. Many of R's standard functions are coded in the R language itself, making it easy to follow their algorithmic flow.
The objective of this tutorial is to illustrate how to directly obtain the objective function value and the post hoc η using R. This tutorial gives a detailed derivation of the FO approximation method in NONMEM®. To be consistent with the terminology, the notations are defined in Table 1 .
Basic principles of the first-order approximation method used in NONMEM®
The following equations are used for PK/PD modelling with NONMEM®:
When F is a function of the predicted value without final residual variability, the observed value (Y) can be expressed as a function of F and residual variability. As shown above, f(ѳ, η, x) represents a structural model describing the relationship between the PK/PD observations and the model parameter ѳ, while η and ε represent the stochastic model components describing the randomness unexplained by the structural model. η represents inter-individual random variability with E(η)=0 and V(η)=ω 2 , whereas ε is the rest residual variability with E(ε)=0 and V(ε)=σ 2 (Therefore, ѳ, Ω and ∑ are constants while η and ε are random variables. Before examining the details of mathematical equations, those not accustomed to mathematics and statistics may wish to view the R script first to more easily understand it.).
The typical PK/PD of the population is summarized by ѳ, and individual PK/PD parameters are expressed as a combination of ѳ and η. For example, systemic clearance is expressed as,
where ѳ CL is the typical value and η CL is the corresponding intersubject variability following normal distribution with mean zero and covariance. In other words, the typical value of a PK/PD parameter is the value of the PK/PD parameter when η = 0. F is called the typical prediction when η = 0, while F is called the individual prediction when η = , the empirical Bayes estimate (EBE) of individual eta. [6] Maximum likelihood estimation (MLE) is the approach used in NONMEM® for estimation of the fixed effect and random effect parameters. [7, 8] The probability (or likelihood) of a series of observations is the product of the probability (or likelihood) of individual observations. Thus, if there are n observations, the combined probability (likelihood) is the product of n individual probabilities (likelihoods), i.e., the likelihood of the i-the subject becomes:
This can be transformed into the -2 log likelihood (-2LL): Number of epsilons
The observation (Y) given by F and the intra-individual variability (ε).
Y i
The observation vector (Y) of i-th subject
Y ij
The j-th observation (Y) of i-th subject
e., residual) random variability modeled using multivariate normal distribution with mean zero and covariance matrix ∑.
η~MVN(0, Ω)
Inter-individual random variability modeled using multivariate normal (MVN) distribution with mean zero and covariance matrix Ω. NONMEM® minimizes the -2 log likelihood. Because the first part of the right side equation, nlog(2π), is a constant (when the observation number n is fixed), minimization was directed to the second part of the right hand side of the above equation that is given by NONMEM® as the objective function value.
Therefore, the objective function for i-th subject (and if the
This function shows that the squared error,
, is weighted by the (inverse of) variance, V(Y i ). However, Sheiner and Beal did not assume a normal distribution for this derivation. Therefore they called this method the 'extended least squares' objective function in NONMEM® [10] [11] [12] instead of the maximum likelihood estimation.
By using a first-order Taylor series approximation of f about true eta value (η t , unknown to the investigator) of η and 0 of ε respectively, E(Y) and V(Y) were derived as follows: For an individual with η t , Because the covariance between η and ε is assumed to be zero, the last term of approximated
In NONMEM®, the FO method assumes η t is zero; therefore, becomes If the POSTHOC option is used, NONMEM® will estimate η based on the final estimates of ѳ, Ω and ∑ for each individual after the end of the estimation step. This estimate of each subject's η( ) has several names -post hoc η, realized η, EBE of η, or maximum a posteriori (MAP) estimate of η. NONMEM® constructs an objective function in order to estimate post hoc η in addition to the objective function for ѳ, Ω and ∑. The objective function for post hoc η in NONMEM® is as follows [6] :
Vector notations
To reproduce the estimation algorithm in the above section using R, equations were converted into vector notation because R is optimized to calculate using vectors. For an individual, Because was approximated by a first-order Taylor series, only the first-order terms for both and were shown. Due to the assumption of multivariate normality of and , the above also follows multivariate normal distribution with mean E( ) and the variance-covariance matrix V( ). Thus, −2LL i were derived by using estimated values for unknown true values as follows:
Thus, the objective function of NONMEM® was denoted as where is called the 'Weighted Residual (WRES)' in NONMEM®, and this equation is the same as the equation in the NONMEM® Users Guide I, p34-41. Because WRES is defined in this way, the sign of WRES could be different from 'Residual (RES)' . could be calculated using spectral decomposition, as was shown in R code 2.
To estimate of true for i-th subject, final estimates of , Ω and ∑ obtained after the end of estimation step were used.
Implementation
Computing environment 
Dataset and population pharmacokinetic model
The THEO dataset in the NONMEM® distribution media was used for exemplary computing of the objective function value. This dataset is readily available, and its use will make it easy to compare the results from other available methods of the future. The THEO dataset has 132 observations from 12 subjects (11 observations per subject following an oral administration of 320 mg theophylline). A one-compartment PK model with firstorder absorption, as shown in the model equations below, was used for the calculation of the objective function value.
where ka, V, k are absorption rate constant, volume of distribution, and elimination rate constant, respectively. 
Computation of objective function value using user-written code in R
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Prior to computing the objective function value in R, two matrix-related functions, one for converting a vector of the lower triangular part to a full matrix (R code 1) and the other for calculating the square-root-inverse of a matrix using spectral decomposition (R code 2), were developed.
The PRED function needs to be coded in R to calculate the F, G, and H vectors or matrices for the objective function value (R code 3). F is the typical prediction in the FO method. G is the partial derivative of F with respect to η evaluated at , which is necessary to calculate the total objective function value for ѳ, Ω and ∑. H is the partial derivative of Y with respect to ε.
Where G1, G2, and G3 are partial derivatives of F with respect to η 1 , η 2 , and η 3 , respectively, and H1 and H2 are the partial derivatives of Y with respect to ε 1 and ε 2 , respectively.
In order to mimic NONMEM® in R, final estimates of ѳ, Ω and ∑ from NONMEM® results were used to calculate the objective function value. For obtaining the final estimates, we used the .xml file from the NONMEM® output files. The objective function value is the sum of individual objective function values (R # R code 3 PRED = function(THETA, ETA, DATA){ DOSE = 320 TIME = DATA$TIME
)*(exp(-K*TIME)-exp(-KA*TIME))+DOSE/ V*KA/(KA-K)*(exp(-KA*TIME)*TIME)) * KA G2 = -(DOSE/V^2*KA/(KA-K)*(exp(-K*TIME)-exp(-KA*TIME))) * V G3 = (DOSE/V*KA/(KA-K)^2*(exp(-K*TIME)-exp(-KA*TIME))-DOSE/V*KA/(KA-K)*(exp(-K*TIME)*TIME)) * K For the POSTHOC process, the OBETA function is necessary to calculate the objective function for post hoc η (R code 5). In order to minimize the objective function values for post hoc η, the 'L-BFGS-B' method in the 'optim' function was used with zero initial values. Additionally, the standard error of post hoc η was calculated (R code 6). [6] After the POSTHOC process, G and H matrices were recalculated using the final estimates of ѳ, Ω, ∑, and for each individual (R code 7).
There was no difference between the estimates in the NON-MEM® output file and the results from our R codes, e.g., F, G, # R code 4 DATASET = read.csv("THEO.csv", header=TRUE) names(DATASET) = c("ID", "AMT", "TIME" 
Summary
The nonlinear mixed effects model aims to describe the data observed in a population of subjects. NONMEM® has become the gold standard, both in the pharmaceutical industry and academia. But it is difficult to understand the estimation methods implemented in NONMEM®. The classical estimation method, FO approximation, is relatively comprehensible compared with other estimation methods. This method was reproduced using the R language, which is more user-friendly and easy to learn than other programming languages such as FORTRAN or C++.
In this tutorial, we demonstrate the calculation steps of the F, G and H vectors or matrices using final estimates of ѳ, Ω, ∑ and the objective function value. In fact, NONMEM® produces the updated ѳ, Ω and ∑ from the ZXMIN1 subroutine to minimize the value of the objective function. ZXMIN1 uses the derivative-free Davidon-Fletcher-Powell algorithm, which is a type of quasi-Newton algorithm. This optimization process for estimation of ѳ, Ω and ∑ is more complex than η and considers bound constraints, scaling, reparameterization, etc. Therefore, we chose not to use this process. We hope that this tutorial helps pharmacometricians understand the underlying estimation process of nonlinear mixed effects modelling.
